Adhesion to E-selectin Promotes Growth Inhibition and Apoptosis of Human and Murine Hematopoietic Progenitor Cells Independent of PSGL-1
Overview
Affiliations
Although both P- and E-selectin are constitutively expressed on bone marrow endothelial cells, their role in the regulation of hematopoiesis has only recently been investigated. We have previously shown that P-selectin glycoprotein ligand-l (PSGL-1/CD162) is expressed by primitive human bone marrow CD34+ cells, mediates their adhesion to P-selectin, and, more importantly, inhibits their proliferation. We now demonstrate that adhesion to E-selectin inhibits the proliferation of human CD34+ cells isolated either from human umbilical cord blood, adult mobilized blood, or steady-state bone marrow. Furthermore, a subpopulation, which does not contain the most primitive hematopoietic progenitor cells, undergoes apoptosis following E-selectin-mediated adhesion. The same phenomenon was observed in cells isolated from mouse bone marrow. Using lineage-negative Sca-1+ c-KIT+ bone marrow cells from PSGL-1(-/-) and wild-type mice, we establish that PSGL-1 is not the ligand involved in E-selectin-mediated growth inhibition and apoptosis. Moreover, stable transfection of the human myeloid cell line K562 (which does not express PSGL-1) with alpha(1,3) fucosyltransferase VII alone was sufficient to recapitulate the E-selectin-mediated growth inhibition and apoptosis observed in hematopoietic progenitor cells. These data demonstrate that an E-selectin ligand(s) other than PSGL-1 transduces growth inhibitory and proapoptotic signals and requires posttranslational fucosylation to be functional.
Grenier J, Testut C, Fauriat C, Mancini S, Aurrand-Lions M Front Immunol. 2021; 12:756231.
PMID: 34867994 PMC: 8636127. DOI: 10.3389/fimmu.2021.756231.
De Vilder E, Martin L, Leftheriotis G, Coucke P, Van Nieuwerburgh F, Vanakker O Front Cell Dev Biol. 2021; 9:612581.
PMID: 34169069 PMC: 8218811. DOI: 10.3389/fcell.2021.612581.
Erbani J, Tay J, Barbier V, Levesque J, Winkler I Front Cell Dev Biol. 2020; 8:668.
PMID: 32793603 PMC: 7393995. DOI: 10.3389/fcell.2020.00668.
Barbier V, Erbani J, Fiveash C, Davies J, Tay J, Tallack M Nat Commun. 2020; 11(1):2042.
PMID: 32341362 PMC: 7184728. DOI: 10.1038/s41467-020-15817-5.
Leveraging fluorinated glucosamine action to boost antitumor immunity.
Dimitroff C Curr Opin Immunol. 2012; 25(2):206-13.
PMID: 23219268 PMC: 3604137. DOI: 10.1016/j.coi.2012.11.003.